日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system

乐伐替尼单药治疗与乐伐替尼联合帕博利珠单抗治疗相关的胃肠道不良事件：一项在FDA不良事件报告系统中进行的药物警戒研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-99773-4
Ding, Chufeng; Ma, Lin; Liang, Yankun; Zhang, Zhenpo; Wu, Qimin; Lyu, Jun; Su, Ling
发表日期：2025
文献求助 收藏

Identification of electric vehicle susceptible to thermal runaway based on risk accumulation

基于风险累积的电动汽车热失控易感性识别

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2025.e42562
Li, Xuan; Lin, Ni; Wang, Zhenpo; Chen, Kang; Zhang, Zhaosheng; Li, Qian
发表日期：2025
文献求助 收藏

Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System

基于年龄分层的克拉霉素不良事件信号分析：利用FDA不良事件报告系统进行比例失衡分析

期刊:Therapeutic Advances in Drug Safety
影响因子:3.4
doi:10.1177/20420986241311231
Mai, Haiyan; Zhang, Zhenpo; Liang, Yankun; Zheng, Jingping; Su, Ling
信号转导
发表日期：2025
文献求助 收藏

Real-world pharmacovigilance study on neonatal congenital anomalies associated with maternal drug exposure using the FDA Adverse Event Reporting System

利用FDA不良事件报告系统开展的关于母体药物暴露与新生儿先天性异常相关的真实世界药物警戒研究

期刊:Therapeutic Advances in Drug Safety
影响因子:3.4
doi:10.1177/20420986251383765
Zheng, Jingping; Zhang, Zhenpo; Ma, Lin; Su, Ling
发表日期：2025
文献求助 收藏

Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database

嵌合抗原受体T细胞疗法相关的血液和淋巴系统疾病：基于FDA不良事件报告系统（FAERS）数据库的药物警戒分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14227-4
Zhang, Zhenpo; Zheng, Jingping; Liang, Yankun; Wu, Qimin; Ding, Chufeng; Ma, Lin; Su, Ling
T细胞
信号转导
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Tirzepatide safety in type 2 diabetes: a disproportionality analysis of adverse events using the FDA FAERS database

替拉帕肽在 2 型糖尿病中的安全性：基于 FDA FAERS 数据库的不良事件比例失衡分析

期刊:Endocrine Connections
影响因子:2.8
doi:10.1530/EC-25-0205
Zhang, Zhenpo; Li, Jiangxiong; Zheng, Jingping; Liang, Yankun; Ma, Lin; Su, Ling
糖尿病
代谢
发表日期：2025
文献求助 收藏

Machine Learning for Selecting High-Energy Phosphate Cathode Materials

利用机器学习选择高能量磷酸盐正极材料

期刊:
影响因子:
doi:10.34133/research.0794
Dang, Yongchun; Li, Zechen; Yu, Yongchao; Bai, Xiwei; Wang, Li; Wang, Xuelei; Liu, Peng; Sun, Chen; Zhou, Xunli; Wang, Zhenpo; Zhao, Yongjie; He, Xiangming; Li, Lei
发表日期：2025
文献求助 收藏

High-fidelity hierarchical modeling of lithium-ion batteries: a cross-scale electrochemical-mechanical framework

锂离子电池的高保真分层建模：跨尺度电化学-力学框架

期刊:Communications Engineering
影响因子:
doi:10.1038/s44172-025-00567-3
Li, Xiaoyu; Zhao, Shen; Gwan, Chiton; Wang, Zhenpo; Jiao, Shuqiang; Zhu, Yanli
发表日期：2025
文献求助 收藏

Age-stratified pharmacovigilance of azithromycin: a multimethod signal detection analysis in the FAERS database

基于年龄分层的阿奇霉素药物警戒：FAERS数据库中的多方法信号检测分析

期刊:Journal of Pharmaceutical Policy and Practice
影响因子:
doi:10.1080/20523211.2025.2525356
Zhang, Zhenpo; Li, Jiangxiong; Zheng, Jingping; Liang, Yankun; Ma, Lin; Su, Ling
信号转导
发表日期：2025
文献求助 收藏

Association of incretin-based therapies with hepatobiliary disorders among patients with type 2 diabetes: a case series from the FDA adverse event reporting system

肠促胰素疗法与2型糖尿病患者肝胆疾病的关联：来自FDA不良事件报告系统的病例系列

期刊:Endocrine Connections
影响因子:2.8
doi:10.1530/EC-24-0404
Liang, Yankun; Zhang, Zhenpo; Zheng, Jingping; Wang, Yuting; He, Jiaxin; Zhao, Juanzhi; Su, Ling
糖尿病
代谢
发表日期：2024
文献求助 收藏